The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / 2015 ACR/ARHP Annual Meeting: Research Provides Insights into Immune Regulation and Tolerance

2015 ACR/ARHP Annual Meeting: Research Provides Insights into Immune Regulation and Tolerance

February 16, 2016 • By Mary Beth Nierengarten

  • Tweet
  • Email
Print-Friendly Version / Save PDF
moomsabuy/shutterstock.com

Image Credit: moomsabuy/shutterstock.com

SAN FRANCISCO—To help rheumatologists better understand the underlying mechanisms of autoimmune diseases, Mark Anderson, MD, PhD, professor of adult endocrinology, University of California, San Francisco, spoke during the 2015 ACR/ARHP Annual Meeting on ways in which immune regulation and tolerance work to ensure health in individuals who maintain tolerance to self-antigens and how these processes fail in those in whom autoimmune disease develops.

You Might Also Like
  • 2015 ACR/ARHP Annual Meeting: Insights into the Microbiome
  • 2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response
  • 2015 ACR/ARHP Annual Meeting: Research Offers Clues to Environmental Triggers of RA
Explore This Issue
February 2016
Also By This Author
  • For RA Patients, Functional Disability May Precede Diagnosis

In his session, Immune Regulation and Tolerance, Dr. Anderson emphasized the key role of immune regulation for adaptive immunity that is characterized by a balancing act between activation effector T cells and tolerance T cells. He said that immune regulation is the way in which the body restrains its response to self antigens or external pathogens that get out of control.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Important to maintaining this balancing act requires controlling key switches that, when turned on inappropriately, can lead to pathogenic disease or autoimmune disease. “We now know that many of these switches have genetic underpinnings and are regulated by reactions to the environment,” said Dr. Anderson.

What We’re Learning from Cancer Immunology

Dr. Anderson

Dr. Anderson

Research in cancer immunology, according to Dr. Anderson, is providing exciting insights into the therapeutic potential of either inhibiting or activating immunity to treat certain cancers.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

He said that an active pathway in drug development is the programmed cell death (PD)-1 pathway. This pathway plays a role in cancer, as well as in chronic infection. He cited research showing T cell expansion in individuals with chronic viral infection, as well as data from mouse experiments showing that the PD-1 pathway helps shut down the response to viral infection to reduce collateral damage to tissue.1

Dr. Anderson also highlighted current investigation into the increasing recognized role that follicular helper T cells are thought to play in balancing the PD-1 pathway (also see “T Follicular Helper Cells,”).

All of this research is being used to develop new cancer drugs, such as ipilimumab, that activate the immune system by targeting CTLA-4, a protein receptor that, when blocked, can help activate T cells so they can attack tumors.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

He cautioned, however, that the use of these types of drugs to treat disease by activating the immune system may also incur risks that may lead to autoimmune reactions and other collateral damage. “In the right context,” he said, “these drugs can promote autoimmune disease.” Thus, he emphasized the need to weigh the severity of potential adverse reactions against the benefits of treatment.

Regulatory T Cells

Another area of active investigation that Dr. Anderson briefly spoke on is immune tolerance and how it is maintained. Critical to understanding how immune tolerance works is to understand the properties of regulatory T cells (Tregs) and how these cells are regulated.

Pages: 1 2 | Single Page

Filed Under: Conditions, Meeting Reports Tagged With: 2015 ACR/ARHP Annual Meeting, American College of Rheumatology, immune response, Regulation, regulatory T cells, Research, rheumatology, T regsIssue: February 2016

You Might Also Like:
  • 2015 ACR/ARHP Annual Meeting: Insights into the Microbiome
  • 2015 ACR/ARHP Annual Meeting: Immune Mediators Can Impact Inflammatory Response
  • 2015 ACR/ARHP Annual Meeting: Research Offers Clues to Environmental Triggers of RA
  • 2015 ACR/ARHP Annual Meeting: Metabolic Pathways Linked with Inflammatory Diseases

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.